In Ovo, a biotechnology start-up specializing in the development of gender-testing technology in eggs, has raised several million euros in further funding from Evonik’s venture capital arm and co-investor VisVires New Protein Capital.

“For the industry, it’s an ethical challenge,” said Mark Redshaw, the investment director at…